Skip to content

Glossary

GHRH

Also called Growth hormone-releasing hormone, GHRH analog, GRF, Somatocrinin

The hormone from the hypothalamus that tells the pituitary to release growth hormone. Sermorelin, tesamorelin and CJC-1295 are GHRH analogs.

In more detail

GHRH works through its own receptor on the pituitary. Analogs keep the active front part of the molecule and modify it to last longer. Tesamorelin is FDA approved for a specific fat-reduction use. Sermorelin was sold in the US as Geref and later discontinued; FDA determined in 2013 that it was not withdrawn for safety or effectiveness reasons. CJC-1295 has never been approved.

GHRH analogs are often paired with a GHRP because the two act on different receptors and community protocols treat them as complementary.

Why it matters

Knowing which side of the pathway a compound works on explains why "CJC-1295 plus ipamorelin" blends exist. Under the WADA list, GHRH analogs are banned in sport at all times.

Peptides where this comes up

Sources

Each source is labeled by where the information comes from. How we label sources

  1. Reference work
    Growth hormone-releasing hormone(opens in a new tab)

    Wikipedia · checked

  2. Regulatory
    Egrifta SV (tesamorelin) label(opens in a new tab)

    DailyMed · checked

  3. Regulatory
    Determination that GEREF (sermorelin acetate) injection was not withdrawn from sale for reasons of safety or effectiveness(opens in a new tab)

    Federal Register · checked

  4. Regulatory
    Prohibited List 2026(opens in a new tab)

    World Anti-Doping Agency · checked

Updated